Khiron Life Sciences (Khiron Life Sciences) Accounts Payable & Accrued Expense : $5.07 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Khiron Life Sciences Accounts Payable & Accrued Expense?

Khiron Life Sciences's quarterly accounts payable & accrued expense increased from Mar. 2022 ($5.08 Mil) to Jun. 2022 ($5.16 Mil) but then declined from Jun. 2022 ($5.16 Mil) to Sep. 2022 ($5.07 Mil).

Khiron Life Sciences's annual accounts payable & accrued expense declined from Dec. 2019 ($5.65 Mil) to Dec. 2020 ($4.89 Mil) and declined from Dec. 2020 ($4.89 Mil) to Dec. 2021 ($3.37 Mil).

Khiron Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Khiron Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Accounts Payable & Accrued Expense Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.09

4.79

5.65

4.89

3.37

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.56	3.37	5.08	5.16	5.07

Khiron Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRWF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.